Skip to content

Dr. Aline Wijnand

Active Private limited companyfounded 2023active for 3 yearsUilkensstraat 79, 9000 GhentKBO/BCE: BE 1001.047.324

Lifetime

3 annual accounts with figures on one time axis
peak of €210,161 in 2025
€210,161▲ 29.6%
peak of €159,244 in 2025
€159,244▲ 27.5%
peak of €290,134 in 2025
€290,134▲ 122%
€49,573▲ 13.7%
Board2 names since 2023
1 director
Documentsfilings and deeds
23-02-2026158 days before the deadline
2025micro format
Gross margin from €162,201 to €210,161Result from €124,892 to €159,244Equity from €130,890 to €290,134Investments €4,124Cash from €167,846 to €320,903

Key points

from the 2025 annual accounts

Equity

€290,134 ▲ 122%
€131,0002024€290,0002025

Equity rose in 2025 from €130,890 to €290,134.

Turnover

≈ €390,000 estimated

The micro format states no turnover.

Investments

€4,124 2.3 times depreciation
202320242025

Green is investment, beige is depreciation.

Liquidity

6.76 was 3.95 in 2024

Short-term debts rose from €43,586 to €49,573.

Position in the sector

€159,244

Higher net result than 82% of companies in human health. Sector median €59,553 · 21,334 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,329 companies had the same profile as Dr. Aline Wijnand has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,329 companies, not a prediction for Dr. Aline Wijnand. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 11-10-2023
  • 100 sharesdeed of 13-10-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1001047324
Incorporation Founding capital of €2,000, 100 shares · Founded by · (statutory director) and (successor statutory director) appointed · published on 13-10-2023 · Gazette deed
First establishment Uilkensstraat 79, Ghent
All 10 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Aline Wijnand Ghent €339,707 €210,161 85.4% -
LC PATHOLOGIE Aalst €342,609 €209,004 92.8% -
Dr. Thomas Couck, Cardiologie Merelbeke-Melle €338,859 €207,725 85.2% -
Verocq Consult Lierde €341,934 €189,300 87.0% -
Dr. Jolien De Meyer, urgentiegeneeskunde Gavere €334,299 €182,413 94.4% -
MCA MEDICAL Charleroi €345,649 €217,783 95.7% -
RIC-CARDIO Chapelle-lez-Herlaimont €323,646 €204,966 89.7% -

These companies have the same main activity as Dr. Aline Wijnand: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €324,000 and €346,000, founded in 2023.

Official details

Source: KBO
Status
Active since 11-10-2023Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.351.251.9879000 Ghent, since 11-10-2023
Financial year end
31 December
Peppol
Reachable since 27-03-2026
Company details

Annual accounts 2025

€339,707▲ 94.7%
Filing
Filed on 23-02-2026, 158 days before the end of the filing period
Financials

Insights on Dr. Aline Wijnand

Dr. Aline Wijnand files the micro format. That format states no turnover. The gross margin rose from €7,204 in 2023 to €210,161 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Aline Wijnand

What is the company number of Dr. Aline Wijnand?
The company number of Dr. Aline Wijnand is 1001.047.324. The VAT number is the same number with BE in front: BE 1001.047.324.
Where is Dr. Aline Wijnand based?
The registered office is at Uilkensstraat 79, 9000 Ghent.Company details
What does Dr. Aline Wijnand do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Aline Wijnand?
Dr. Aline Wijnand is a private limited company (BV).
When was Dr. Aline Wijnand founded?
Dr. Aline Wijnand was founded on 11-10-2023.
Is Dr. Aline Wijnand still active?
Yes, Dr. Aline Wijnand is an active enterprise in the KBO register.
What is the turnover of Dr. Aline Wijnand?
The turnover in financial year 2025 is ≈ €390,000. This figure is estimated from the gross margin of €210,161 and 40 comparable companies (NACE 86220). It probably lies between €330,000 and €520,000.Financials
Is Dr. Aline Wijnand profitable?
In financial year 2025, Dr. Aline Wijnand made a profit of €159,244.
Where can I find the annual accounts of Dr. Aline Wijnand?
Dr. Aline Wijnand filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Aline Wijnand due?
Dr. Aline Wijnand must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.